SCHEMBL7085381

SCHEMBL7085381

Fc1ccc(-c2ccc3cc[nH]c3c2)c(F)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 4/20 0.65
GPR84 Q9NQS5 1/20 0.47
TDP2 O95551 1/20 0.46
APP P05067 1/20 0.43
FGFR1 P11362 1/20 0.42
FGFR2 P21802 1/20 0.42
FFAR4 Q5NUL3 1/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
USP2 O75604 1/20 0.42
ALDH1A1 P00352 1/20 0.42
DHFR P00374 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
LMNA P02545 1/20 0.42
TTR P02766 1/20 0.42
ALB P02768 1/20 0.42
HMGB1 P09429 1/20 0.42
HPGD P15428 1/20 0.42
CXCL12 P48061 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7091087 0.87 AHR (0.65) AHRGPR84TDP2APPCA1
SCHEMBL5662434 0.81 GUSB (0.54) AHRGPR84APPFFAR4CA1
SCHEMBL147946 0.80 AHR (0.70) AHRGPR84APPFFAR4KDM4E
SCHEMBL29361924 0.80 AHR (1.00) AHRGPR84APPKDM4EMEN1
SCHEMBL18805062 0.80 AHR (1.00) AHRGPR84APPKDM4EMEN1
SCHEMBL444450 0.80 AHR (1.00) AHRGPR84APPKDM4EMEN1
Methane SCHEMBL28804924 0.78 AHR (0.95) AHRGPR84APPKDM4EMEN1
SCHEMBL7087919 0.76 AHR (0.63) AHRGPR84APPFFAR4CMA1
SCHEMBL20370288 0.75 LCK (0.49) AHRKDM4EMEN1ALDH1A1HPGD
SCHEMBL844328 0.75 PIM3 (0.61) AHRTDP2KDM4EMEN1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030203959-A1 Novel modulators of potassium channels 4SC AG (DE) 2003-10-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030203959-A1 Novel modulators of potassium channels HCN3, KCNN3, KCNN1 AHR 379/4885GPR84 546/4885TDP2 4439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.